ArticleCell reports. Medicine2025

EGFR TKIs suppress MUC1 glycosylation through the PI3K/AKT/SP1/C1GALT1 pathway to enhance TnMUC1 CAR-T efficacy in EGFR-mutant NSCLC.

Ziwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.